bf/NASDAQ:LXRX_icon.jpeg

NASDAQ:LXRX

Lexicon Pharmaceuticals, Inc.

  • Stock

USD

Last Close

1.94

16/05 20:00

Market Cap

445.76M

Beta: 1.33

Volume Today

1.59M

Avg: 593.73K

PE Ratio

−3.21

PFCF: −3.75

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
2.22M
-
22.85M
928.53%
130.01M
468.89%
83.34M
35.90%
90.33M
8.40%
63.21M
30.03%
322.07M
409.54%
24.00M
92.55%
298K
98.76%
139K
53.36%
1.20M
766.19%
cost of revenue
1.90M
-
2.49M
31.17%
3.23M
29.71%
1.93M
40.30%
55.05M
2,753.60%
427K
99.22%
639K
49.65%
gross profit
2.22M
-
22.85M
928.53%
130.01M
468.89%
83.34M
35.90%
88.44M
6.12%
60.72M
31.34%
318.84M
425.12%
22.07M
93.08%
-54.75M
348.11%
-288K
99.47%
565K
296.18%
selling and marketing expenses
general and administrative expenses
17.12M
-
19.41M
13.38%
23.84M
22.79%
43.04M
80.59%
66.20M
53.80%
63.75M
3.70%
48.08M
-
selling general and administrative expenses
17.12M
-
19.41M
13.38%
23.84M
22.79%
43.04M
80.59%
66.20M
53.80%
63.75M
3.70%
56.84M
10.85%
47.23M
16.90%
32.34M
31.52%
48.08M
48.67%
113.98M
137.05%
research and development expenses
89.68M
-
89.28M
0.45%
95.19M
6.62%
178.15M
87.16%
156.81M
11.98%
100.24M
36.07%
91.92M
8.30%
153.62M
67.12%
55.05M
64.17%
52.82M
4.05%
58.33M
10.45%
other expenses
59K
-
2.25M
3,722.03%
572K
74.63%
2.29M
300.87%
1.95M
14.78%
28.64M
-
1.60M
94.41%
cost and expenses
106.80M
-
108.69M
1.77%
119.02M
9.51%
221.19M
85.84%
224.91M
1.68%
166.49M
25.98%
151.99M
8.71%
202.78M
33.42%
87.39M
56.91%
100.90M
15.46%
172.95M
71.41%
operating expenses
106.80M
-
108.69M
1.77%
119.02M
9.51%
221.19M
85.84%
223.02M
0.82%
164.00M
26.46%
148.76M
9.29%
200.85M
35.02%
87.39M
56.49%
100.90M
15.46%
172.31M
70.78%
interest expense
1.97M
-
2.25M
14.31%
6.72M
198.36%
6.57M
2.31%
6.98M
6.35%
20.78M
197.49%
20.68M
0.49%
14.54M
29.66%
802K
94.49%
2.78M
246.63%
13.10M
371.26%
ebitda
-104.36M
-
-83.58M
19.91%
11.56M
113.84%
-135.56M
1,272.30%
-132.63M
2.17%
-99.77M
24.77%
173.43M
273.83%
-176.02M
201.49%
-86.96M
50.60%
-99.16M
14.04%
-171.20M
72.64%
operating income
-102.37M
-
-100.37M
1.96%
1.47M
101.46%
-137.16M
9,442.98%
-136.68M
0.35%
-103.28M
24.44%
141.44M
236.95%
-178.78M
226.40%
-87.09M
51.29%
-100.76M
15.70%
-171.75M
70.45%
depreciation and amortization
2.86M
-
1.93M
32.66%
727K
62.29%
2.06M
182.81%
3.40M
65.32%
3.68M
8.36%
31.99M
768.53%
2.77M
91.35%
134K
95.16%
1.60M
1,091.04%
554K
65.29%
total other income expenses net
2.27M
-
-14.53M
740.37%
-9.52M
34.45%
703K
107.38%
-2.10M
398.86%
-17.27M
721.94%
-17.33M
0.33%
120.21M
793.82%
-668K
100.56%
-1.18M
77.25%
-5.37M
353.46%
income before tax
-104.13M
-
-100.36M
3.61%
-4.68M
95.33%
-141.43M
2,920.70%
-141.71M
0.20%
-120.55M
14.93%
124.12M
202.96%
-58.57M
147.19%
-87.76M
49.82%
-101.94M
16.16%
-177.12M
73.74%
income tax expense
-833K
-
-70K
91.60%
6.00M
8,664.29%
4.51M
24.75%
-12.66M
380.67%
3.51M
127.71%
-6.01M
271.44%
11.61M
293.05%
510K
95.61%
1.18M
132.16%
net income
-104.13M
-
-100.29M
3.68%
-4.68M
95.33%
-141.43M
2,920.70%
-129.05M
8.75%
-120.55M
6.59%
130.13M
207.95%
-70.18M
153.93%
-88.27M
25.77%
-103.13M
16.84%
-177.12M
71.75%
weighted average shs out
73.30M
-
76.35M
4.15%
103.59M
35.68%
103.86M
0.26%
105.12M
1.21%
105.74M
0.59%
106.22M
0.45%
110.84M
4.35%
145.65M
31.41%
165.73M
13.79%
221.13M
33.43%
weighted average shs out dil
73.30M
-
76.35M
4.15%
103.59M
35.68%
103.86M
0.26%
105.24M
1.32%
105.83M
0.56%
116.75M
10.32%
110.84M
5.06%
145.65M
31.41%
165.73M
13.79%
221.13M
33.43%
eps
-1.42
-
-1.31
7.75%
-0.05
96.55%
-1.36
2,908.85%
-1.23
9.56%
-1.14
7.32%
1.23
207.89%
-0.63
151.22%
-0.61
3.17%
-0.62
1.64%
-0.80
29.03%
epsdiluted
-1.42
-
-1.31
7.75%
-0.05
96.55%
-1.36
2,908.85%
-1.23
9.56%
-1.14
7.32%
1.11
197.37%
-0.63
156.76%
-0.61
3.17%
-0.62
1.64%
-0.80
29.03%

All numbers in USD (except ratios and percentages)